JUAWANNA SCHULLER: Open Payments
NPI 1528036100 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,774 in 296 payments from 26 companies in 2025. Trend: 2023 $4,311 · 2024 $5,360 · 2025 $6,774
Food & beverage: $6,263Travel & lodging: $464Education: $47
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 10 | $1,161 |
| ABBVIE INC. | 75 | $931 |
| UCB, Inc. | 24 | $531 |
| Amgen Inc. | 9 | $504 |
| Novartis Pharmaceuticals Corporation | 25 | $466 |
| PFIZER INC. | 39 | $399 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $326 |
| Biogen, Inc. | 14 | $316 |
| Teva Pharmaceuticals USA, Inc. | 14 | $314 |
| Alexion Pharmaceuticals, Inc. | 11 | $274 |
Products named: VNS Therapy, BOTOX, KESIMPTA, UPLIZNA, QULIPTA, HYQVIA, AUSTEDO XR, ULTOMIRIS.
Industry payments across KY — which companies pay providers there.
